Overview

Continuous Infusion of Fentanyl in Preterm on MV

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The objective of this randomized, double-blind trial is to compare the efficacy and safety of 2 therapeutic regimens of fentanyl administration in a population of preterm newborns of GA <= 32 weeks in MV: - Group A) continuous infusion of Fentanyl + open label boluses of Fentanyl; - Group B) continuous infusion of placebo + open label boluses of Fentanyl.
Phase:
Phase 3
Details
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
St. Orsola Hospital
Collaborator:
Agenzia Italiana del Farmaco
Treatments:
Fentanyl